We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Parkinson's disease

News List

On the Trail of Parkinson's Disease dddmag
April 01, 2017
The human brain contains large quantities of the small alpha-synuclein protein. Its exact biological function is still unknown, yet it is closely linked to Parkinson's disease; the protein "clumps together" in the nerve cells of Parkinson patients.
FDA clears Newron, Zambon, US WorldMeds' Xadago for Parkinson's disease firstwordpharma
March 22, 2017
The FDA approved Newron Pharmaceuticals, Zambon and US WorldMeds' Xadago (safinamide) as an add-on therapy to levodopa/carbidopa for patients with Parkinson's disease, the companies announced Tuesday.
Acorda's experimental Parkinson's disease drug CVT-301 hits main goal of late-stage trial firstwordpharma
February 10, 2017
Acorda Therapeutics' experimental drug CVT-301 demonstrated a significant improvement in motor function versus placebo in people with Parkinson's disease experiencing OFF periods in a Phase III study, the company reported.
Zambon and Seqirus partner for Parkinson's disease product in Australia and New Zealand pharmaceutical-technology
January 13, 2017
Italian company Zambon and Australian-based Seqirus have collaborated for Parkinson's disease (PD) product, Xadago, in Australia and New Zealand.

Previous page 1 2 3 Next page